Bio-Rad Laboratories, Inc. (BIO.B) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Bio-Rad Laboratories, Inc. (BIO.B) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $8.48B, listed on NYSE, employing roughly 7,700 people, carrying a beta of 1.06 to the broader market. Bio-Rad Laboratories, Inc. Led by Norman D. Schwartz, public since 1999-09-21.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for BIO.B as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →